Medical Oncology Weekly Journal Club
20 APR 2021
Speaker: Dr LEUNG Ching Yu, Roland
Updates on current therapies and drug development on Advanced Renal Cell Carcnoma
27 APR 2021
Speaker: Dr. LI Cho Wing, Bryan
Endometrial carcinoma as a model of development of immunotherapy
25 MAY 2021
Speaker: Miss Vox Ting
Immunoprofiling as biomarker for response to immunotherapy in advanced hepatocellular carcinoma
01 JUN 2021
Speaker: Dr. YAU Chung Cheung, Thomas
Management of immunotherapy related side-effects
06 JUL 2021
Speaker: Dr. YAU Chung Cheung, Thomas
The use of Tyrosine Kinase Inhibitors in Advanced HCC patients refractory to Immunotherapy Treatment
13 JUL 2021
Speaker: Dr. CHIU Wing Yan, Joanne
Phase III OlympiA: Interim Analysis of Adjuvant Olaparib vs Placebo in BRCA-Mutated, HER2-Negative, High-Risk Early Breast Cancer
04 MAY 2021
Speaker: Dr. YAU Chung Cheung, Thomas
Updates on Advanced liver cancer
11 MAY 2021
Speaker: Dr. WONG Jeffrey
TKIs in post immunotherapy aHCC patients
A joint Hong Kong-Singapore study
08 JUN 2021
Speaker: Dr. CHIU Wing Yan, Joanne
To be updated
22 JUN 2021
Speaker: Dr. CHAN Hoi Wai
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma
20 JUL 2021
Speaker: Dr. LEUNG Ching Yu, Roland
Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Study
03 AUG 2021
Speaker: Mr. Hu Ye Fan
Rational Design of Synthetic Vaccine
17 AUG 2021
Speaker: Dr. KWOK Gin Wai, Gerry
Melanoma: QMH updates and directions for 2021
24 AUG 2021
Speaker: Dr. CHIU Wing Yan, Joanne
Real world experience of palbociclib in HR+ breast cancer
21 SEP 2021
Speaker: Dr. WONG Jeffrey
Nivolumab/ pembrolizumab in Child-Pugh B/C patients with advanced HCC
28 SEP 2021
Speaker: Dr LEUNG Ching Yu, Roland
Cervical Cancer: Summary of Available Treatments
19 OCT 2021
Speaker: Dr. TSANG Wing Yan, Josephine
CA209-459 Tumor-based Genomic Analyses
2 NOV 2021
Speaker: Dr. YAU Chung Cheung, Thomas
To be updated
07 SEP 2021
Speaker: Dr. YAU Chung Cheung, Thomas
Management of Immunotherapy iRAE
14 SEP 2021
Speaker: Dr. KWOK Gin Wai, Gerry
Immune Related AE (IRAE) in the Real World
5 OCT 2021
Novartis – ESMO Sharing
12 OCT 2021
Speaker: Dr. Kenny KAM
Trastuzumab Deruxtecan (T-DXd) vs Trastuzumab Emtansine (T-DM1) in Patients With HER2+ Metastatic Breast Cancer: Results of the Randomized, Phase 3 Study DESTINY – Breast03
16 NOV 2021
Speaker: Dr. LI Cho Wing, Bryan
To be updated
23 NOV 2021
Speaker: Dr. Ronald CHEUK
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage ID-IIIA non-small-cell lung cancer (Impower010): a randomised, multicentre, open-label, phase 3 trial
7 DEC 2021
Speaker: Dr. Carmen WONG
To be updated
14 DEC 2021
Speaker: Dr. KWOK Gin Wai, Gerry
To be updated
-
-
-
-